Our Mission
PulseMedica is laser-focused on improving the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease.
Backed by Leading Investors
Our Story
PulseMedica's Founding Story
PulseMedica’s story began when Dr. Nir Katchinskiy completed his PhD under the supervision of Prof. Abdulhakem Elezzabi at the University of Alberta. Their research focused on femtosecond laser-tissue interaction.
In 2020, Nir participated in the Creative Destruction Lab - Rockies (CDL-R) program where he met Eric Martin, who was pursuing his MBA at the University of Alberta.
United by their commitment and passion for enacting change for those suffering from eye disease, Abdul, Nir, and Eric co-founded PulseMedica with invaluable guidance and support from CDL-R mentors.
Leadership at PulseMedica
We believe that leadership isn't just a position but a commitment to inspiring, innovating, and empowering others to achieve success. Meet the leadership team at PulseMedica: Nir Katchinskiy, Eric Martin, and Thas Yuwaraj.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
What We Strive For
Short-Term Vision
Screen and Treat Symptomatic Eye Floaters
Become the global expert in non-invasive, safe, effective imaging and treatment of floaters.
Long-Term Vision
Address Additional Vitreoretinal Eye Disease
Become the global standard for screening and treating vitreoretinal disease.
